Valuation (14%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.04 | N/A |
| PEG Ratio (TTM) | 1.76 | N/A |
| P/S Ratio (TTM) | 2.93 | N/A |
| P/B Ratio (TTM) | -1.00 | N/A |
| P/FCF Ratio (TTM) | -3.82 | N/A |
| Price to 5YR AVG Earnings Ratio | -0.66 | N/A |
| Price to 5YR AVG FCF Ratio | -1.56 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -40.37% | N/A |
| ROE (TTM) | -504.59% | N/A |
| Net Profit Margin (TTM) | -143.32% | N/A |
| ROIC 5YR AVG | 111.49% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -253.82% | -863,292.72% | -518,069.58% |
| Revenue | 77.40% | 24.33% | 42.75% |
| Net Income | -1,458.18% | -787,825.51% | -472,793.78% |
| Cash Flow | -6.07% | -826,050.45% | -495,634.08% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.52 | N/A |
| Quick Ratio (TTM) | 5.41 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -0.26 | N/A |
| Shares Outstanding Growth 5YR AVG | 67.52% | N/A |